Principles of Reconstructing the Subclonal Architecture of Cancers
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Most cancers evolve from a single founder cell through a series of clonal expansions that are driven by somatic mutations.These clonal expansions can lead to several coexisting subclones sharing subsets of mutations.Analysis of massively parallel sequencing data can infer a tumor's subclonal composition through the identification of populations of cells with shared mutations.We describe the principles that underlie subclonal reconstruction through single nucleotide variants (SNVs) or copy number alterations (CNAs) from bulk or single-cell sequencing.These principles include estimating the fraction of tumor cells for SNVs and CNAs, performing clustering of SNVs from single-and multisample cases, and single-cell sequencing.The application of subclonal reconstruction methods is providing key insights into tumor evolution, identifying subclonal driver mutations, patterns of parallel evolution and differences in mutational signatures between cellular populations, and characterizing the mechanisms of therapy resistance, spread, and metastasis.C ancers evolve through the acquisition of changes in the genome and epigenome of their cells (Nowell 1976;Tabin et al. 1982).Some of these mutations provide the cell in which they occurred with an evolutionary advantage over other cells and are known as "driver" mutations, whereas other mutations ("passenger" mutations) are assumed to have a neutral effect (Stratton et al. 2009;Garraway and Lander 2013).A tumor cell with a selective advantage is better suited to its local microenvironment and can, therefore, proliferate quicker than other cells and generate more daughter cells.This process is called "clonal expansion" (Greaves and Maley 2012;Vogelstein et al. 2013).This interplay between mutation and selection allows a tumor to evolve and adapt to a changing environment.Part of a tumor's evolutionary story can be inferred through massively parallel sequencing of tumor samples (Fig. 1).Mutations that have occurred before the "most recent common ancestor" (MRCA) are carried by all tumor cells in a sample and can be used as markers of the clonal population (Campbell et al. 2008).As the tumor develops further, it continues to acquire more driver and passenger mutations.A tumor cell that acquires an additional driver
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863 · cited 2×
“This process is called “clonal expansion” (Greaves and Maley 2012; Vogelstein et al. 2013).”
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
Greaves, M., & Maley, C. C. (2012) · Nature · doi:10.1038/nature10762 · Cited by 3,162
The Life History of 21 Breast Cancers
Nik-Zainal, S., Van Loo, P., Wedge, D. C., Alexandrov, L. B., Greenman, C. D., Lau, K. W., Raine, K., Jones, D., Marshall, J., Ramakrishna, M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.023 · Cited by 1,443 · cited 7×
“…ic in e. o rg tion of tumor cells 1-t shows copy number state nA,2 + nB,2, t can be calculated as t ¼ 1 rþ rnB;2 2hf ð1 rÞ hf rðnA;2 þ nB;2Þ hf rðnA;1 þ nB;1Þ hf rðnA;2 þ nB;2Þ rnB;1 þ rnB;2 : (20) The principles outlined above are implemented in the Battenberg algorithm (Nik-Zainal et al. 2012).”
BackgroundMethodInfluentialSelf-citationMechanism of activation of a human oncogene
Tabin, C. J., Bradley, S. M., Bargmann, C. I., Weinberg, R. A., Papageorge, A. G., Scolnick, E. M., Dhar, R., Lowy, D. R., & Chang, E. H. (1982) · Nature · doi:10.1038/300143a0 · Cited by 1,393
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia
Landau, D. A., Carter, S. L., Stojanov, P., McKenna, A., Stevenson, K., Lawrence, M. S., Sougnez, C., Stewart, C., Sivachenko, A., Wang, L., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.019 · Cited by 1,379
Genome-Wide Detection of Single-Nucleotide and Copy-Number Variations of a Single Human Cell
Zong, C., Lu, S., Chapman, A. R., & Xie, X. S. (2012) · Science · doi:10.1126/science.1229164 · Cited by 1,154 · cited 2×
“…from uneven coverage and allele dropouts, errors introduced during whole genome amplification resulting in false positive SNV calls, and in some cases two cells are inadvertently sequenced together (called “doublets”) (Hou et al. 2012; Zong et al. 2012; Voet et al. 2013; Van Loo and Voet 2014).”
BackgroundSpatial and temporal diversity in genomic instability processes defines lung cancer evolution
de Bruin, E. C., McGranahan, N., Mitter, R., Salm, M., Wedge, D. C., Yates, L., Jamal-Hanjani, M., Shafi, S., Murugaesu, N., Rowan, A. J., et al. (2014) · Science · doi:10.1126/science.1253462 · Cited by 1,117 · cited 1×
“Mutational processes can differ between clones and subclones through spatially (De Bruin et al. 2014) and temporally (Bolli et al. 2014) separated samples from the same cancer.”
BackgroundSelf-citationHeterogeneity of genomic evolution and mutational profiles in multiple myeloma
Bolli, N., Avet-Loiseau, H., Wedge, D. C., Van Loo, P., Alexandrov, L. B., Martincorena, I., Dawson, K. J., Iorio, F., Nik-Zainal, S., Bignell, G. R., et al. (2014) · Nature Communications · doi:10.1038/ncomms3997 · Cited by 875
Self-citationClonal status of actionable driver events and the timing of mutational processes in cancer evolution
McGranahan, N., Favero, F., de Bruin, E. C., Birkbak, N. J., Szallasi, Z., & Swanton, C. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa1408 · Cited by 685 · cited 1×
“McGranahan et al. (2015) reported that subclonal mutations in known drivers are common across 2694 exome-sequenced tumors representing 9 cancer types from The Cancer Genome Atlas (TCGA).”
Background
Cited by
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes
Dentro, S. C., Leshchiner, I., Haase, K., Tarabichi, M., Wintersinger, J., Deshwar, A. G., Yu, K., Rubanova, Y., Macintyre, G., Demeulemeester, J., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.009 · Cited by 533
Self-citationA clinically applicable integrative molecular classification of meningiomas
Nassiri, F., Liu, J., Patil, V., Mamatjan, Y., Wang, J. Z., Hugh-White, R., Macklin, A. M., Khan, S., Singh, O., Karimi, S., et al. (2021) · Nature · doi:10.1038/s41586-021-03850-3 · Cited by 449
Promises and challenges of adoptive T-cell therapies for solid tumours
Morotti, M., Albukhari, A., Alsaadi, A., Artibani, M., Brenton, J. D., Curbishley, S. M., Dong, T., Dustin, M. L., Hu, Z., McGranahan, N., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01353-6 · Cited by 269
Self-citationOrdered and deterministic cancer genome evolution after p53 loss
Baslan, T., Morris, J. P., Zhao, Z., Reyes, J., Ho, Y.-J., Tsanov, K. M., Bermeo, J., Tian, S., Zhang, S., Askan, G., et al. (2022) · Nature · doi:10.1038/s41586-022-05082-5 · Cited by 221
Lenis, A. T., Ravichandran, V., Brown, S., Alam, S. M., Katims, A., Truong, H., Reisz, P. A., Vasselman, S., Nweji, B., Autio, K. A., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-3403 · Cited by 80
Metadata
- Authors
- Dentro, S. C., Wedge, D. C., & Van Loo, P.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2017-03-07
- Volume
- 7
- Issue
- 8
- Pages
- a026625
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2594380361
- Cited by
- 145
- References
- 10
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Principles of Reconstructing the Subclonal Architecture of Cancers. https://app.cochat.ai/papers/10.1101/cshperspect.a026625
- The paper
- Dentro, S. C., Wedge, D. C., & Van Loo, P. (2017). Principles of Reconstructing the Subclonal Architecture of Cancers. Cold Spring Harbor Perspectives in Medicine. https://doi.org/10.1101/cshperspect.a026625
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.